JP2011529477A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529477A5
JP2011529477A5 JP2011520509A JP2011520509A JP2011529477A5 JP 2011529477 A5 JP2011529477 A5 JP 2011529477A5 JP 2011520509 A JP2011520509 A JP 2011520509A JP 2011520509 A JP2011520509 A JP 2011520509A JP 2011529477 A5 JP2011529477 A5 JP 2011529477A5
Authority
JP
Japan
Prior art keywords
fluoro
indacene
aza
oxa
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2011520509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/059829 external-priority patent/WO2010012789A1/en
Publication of JP2011529477A publication Critical patent/JP2011529477A/ja
Publication of JP2011529477A5 publication Critical patent/JP2011529477A5/ja
Abandoned legal-status Critical Current

Links

JP2011520509A 2008-07-30 2009-07-29 1,6−ジヒドロ−2h−3−オキサ−6−アザ−as−インダセン化合物 Abandoned JP2011529477A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08161485 2008-07-30
EP08161485.1 2008-07-30
PCT/EP2009/059829 WO2010012789A1 (en) 2008-07-30 2009-07-29 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds

Publications (2)

Publication Number Publication Date
JP2011529477A JP2011529477A (ja) 2011-12-08
JP2011529477A5 true JP2011529477A5 (cg-RX-API-DMAC7.html) 2012-08-30

Family

ID=41138660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011520509A Abandoned JP2011529477A (ja) 2008-07-30 2009-07-29 1,6−ジヒドロ−2h−3−オキサ−6−アザ−as−インダセン化合物

Country Status (16)

Country Link
US (1) US8227501B2 (cg-RX-API-DMAC7.html)
EP (1) EP2350088A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011529477A (cg-RX-API-DMAC7.html)
KR (1) KR20110041495A (cg-RX-API-DMAC7.html)
CN (1) CN102112480A (cg-RX-API-DMAC7.html)
AR (1) AR075262A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009275918A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0916395A2 (cg-RX-API-DMAC7.html)
CA (1) CA2731405A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011000184A1 (cg-RX-API-DMAC7.html)
MX (1) MX2011001062A (cg-RX-API-DMAC7.html)
PE (1) PE20110208A1 (cg-RX-API-DMAC7.html)
RU (1) RU2011107443A (cg-RX-API-DMAC7.html)
TW (1) TW201018695A (cg-RX-API-DMAC7.html)
UY (1) UY32016A (cg-RX-API-DMAC7.html)
WO (1) WO2010012789A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601683B (zh) * 2010-04-16 2016-03-30 中国科学院上海药物研究所 苯并杂环类化合物及其制备方法和用途
AR091699A1 (es) * 2012-07-10 2015-02-25 Astellas Pharma Inc Derivado de indol carboxamida
CN104109143B (zh) * 2013-04-22 2018-04-27 上海阳帆医药科技有限公司 一类褪黑激素(mt1-mt2)受体激动剂及其制备方法与用途
CN104326916B (zh) * 2014-10-10 2017-09-22 青岛农业大学 2‑氟‑4‑烯丙基‑6‑硝基苯酚与2‑氟‑4‑硝基‑6‑烯丙基苯酚的联合制备及用途
MY203941A (en) * 2016-06-17 2024-07-25 Daewoong Pharmaceutical Co Ltd Method for producing diphenylmethane derivative
CA3244229A1 (en) * 2021-12-24 2023-06-29 Psylo Pty Ltd COMPOUNDS
KR20240044190A (ko) * 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
EP0126630B1 (en) 1983-05-18 1987-09-16 Monash University The use of melatonin for the manufacture of a medicament
WO1989001472A1 (en) 1987-08-17 1989-02-23 Nelson Research & Development Co. Melatonin analogues
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
WO1997001539A1 (en) 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
US5732360A (en) 1995-09-08 1998-03-24 At & T Wireless Services And Atmel Corp Mobile telecommunication device and method used for changing wireless communication between base stations of different kinds
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
WO1997032871A1 (en) 1996-03-08 1997-09-12 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
FR2771739B1 (fr) 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2784375B1 (fr) 1998-10-12 2000-11-24 Adir Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2793793B1 (fr) 1999-05-19 2004-02-27 Adir Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU6595100A (en) 1999-08-20 2001-03-19 Takeda Chemical Industries Ltd. Percutaneous absorption agents
FR2799757B1 (fr) 1999-10-15 2001-12-14 Adir Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
US6908931B2 (en) 2003-04-10 2005-06-21 Bristol-Myers Squibb Company Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists
WO2005062992A2 (en) 2003-12-23 2005-07-14 Abraxis Bioscience, Inc Substituted melatonin derivatives, process for their preparation, and methods of use

Similar Documents

Publication Publication Date Title
JP6155280B2 (ja) フェニルアルキルカルバメート誘導体化合物およびこれを含む薬学組成物
JP2007516941A5 (cg-RX-API-DMAC7.html)
JP2022516575A (ja) ケタミン誘導体およびその組成物
JP2015512951A5 (cg-RX-API-DMAC7.html)
HRP20170095T1 (hr) Novi kristalni oblik iii agomelatina, postupak za njegovu pripravu i farmaceutski pripravci istog
JP2020524679A5 (cg-RX-API-DMAC7.html)
RU2011107443A (ru) Индаценовые соединения, фармацевтическая композиция и лекарственное средство на их основе, способ их получения и способ лечения или профилактики состояний, связанных с нарушением функционирования систем, регулируемых мелатонином, с их помощью
JP2004534816A5 (cg-RX-API-DMAC7.html)
JP2005508349A5 (cg-RX-API-DMAC7.html)
JP2018519329A5 (cg-RX-API-DMAC7.html)
JP5838226B2 (ja) フェニルカルバメート誘導体の製造方法
JP2010522709A5 (cg-RX-API-DMAC7.html)
JP2012523440A5 (cg-RX-API-DMAC7.html)
JP2005539045A5 (cg-RX-API-DMAC7.html)
JP2011530521A5 (cg-RX-API-DMAC7.html)
NZ590951A (en) Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders
JP2020517607A5 (cg-RX-API-DMAC7.html)
JP2010522711A5 (cg-RX-API-DMAC7.html)
JP5774694B2 (ja) フェニルカルバメート化合物およびこれを含む筋肉弛緩剤
JP2014518552A5 (cg-RX-API-DMAC7.html)
JP2008521775A5 (cg-RX-API-DMAC7.html)
JP2022512373A5 (cg-RX-API-DMAC7.html)
WO2010055911A1 (ja) ビフェニルアセトアミド誘導体
JP2011500763A5 (cg-RX-API-DMAC7.html)
JP2019535715A5 (cg-RX-API-DMAC7.html)